FIELD-APPLICABLE SEROLOGIC DIAGNOSIS AND EXPERIMENTAL CONTROL STRATEGIES
FIELD-APPLICABLE SEROLOGIC DIAGNOSIS AND EXPERIMENTAL CONTROL STRATEGIES
批准号:
6235240
负责人:
ROBERT H GILMAN
金额:
$7.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 1998-04-30
关键词:
Cestoda Peru anthelmintics clinical trials communicable disease control cooperative study diagnosis design /evaluation diagnostic tests disease reservoirs epidemiology feces analysis field study health education helminthiasis human subject human therapy evaluation humoral immunity immunoglobulin G immunoglobulin isotypes nonhuman therapy evaluation parasitic disease chemotherapy parasitic disease diagnosis serology /serodiagnosis swine western blottings
中文摘要
人类猪带绦虫囊虫病是一种严重虚弱的疾病,但
可治愈的疾病。在猪身上,这种感染占了数百万
每年造成的经济损失高达10美元。初步流行病学调查
随着新开发的免疫印迹试验(EITB)在许多拉丁美洲
国家、中国和印度表示,这是一个意义重大的公众
健康问题,人类患病率从8%到15%不等,
在猪中高达45%。
美国疾病控制中心最近的一项调查显示,内源性传播
在有移民家庭佣工的家庭中,导致血清-
仅在布鲁克林一个社区的患病率就高达13%。囊虫病
因此,获得了一种国内模式。对这一重要公众的控制
健康问题取决于患者的识别和治疗
还有猪。
我们建议扩展和增强功能、有用性和实用性
我们独特的化验/现场操作系统用于检测和
控制这一重要疾病。我们还建议测试其疗效
一种新的猪/人方法来监测和控制
囊虫病。
我们将:1.开发低成本、健壮、适用于现场的版本
人和猪囊虫病2的EITB检测方法,
确定接受治疗的患者感染特异性抗体的寿命
患者通过定量同型分析3,以检验假设一个
一次处理EITB阳性猪,同时取消胶带
在血清阳性的人类患者中,蠕虫和排泄是一种可行和
控制人和猪囊虫病的有效途径4,
确定无囊虫病猪的血清学是否有用和
衡量疾病流行和控制的有效哨兵
人类囊虫病的有效性。
英文摘要
Human Taenia solium cysticercosis is a severely debilitating, yet
treatable disease. In the pig, this infection accounts for multimillion
dollars of economic loss per year. Preliminary epidemiological surveys
with the newly developed immmunoblot assay (EITB) in many Latin American
countries, China, and India indicated that this is a significant public
health problem with prevalence rates ranging from 8% to 15% in humans and
up to 45% in pigs.
A recent Centers for Disease Control Survey showed endogenous transmission
in families with immigrant domestic workers, resulting in a sero-
prevalence of 13% in a single community in Brooklyn alone. Cysticercosis
has therefore, acquired a domestic mode. Control of this important public
health problem is dependent on the identification and treatment of patient
and pigs.
We propose to extend and enhance the power, usefulness, and practicality
of our unique assay/field operation system toward the detection and
control of this important disease. We also propose to test the efficacy
of a novel pig/human approach to surveillance and control of
cysticercosis.
We will: 1. To develop a low cost, robust, and field applicable version
of the EITB assay for the detection of human and pig cysticercosis 2,
determine the longevity of infection-specific antibodies in treated
patients by quantitative isotype assays 3, To test the hypothesis that a
single treatment of EITB positive pigs, together with elimination of tape
worms in sero-positive human patients, and eduction is a viable and
effective approach to the control of human and pig cysticercosis 4, to
determine if the serology of cysticercosis-free pigs is a useful and
effective sentinel for measuring disease prevalence and control
effectiveness of human cysticercosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Infectious Diseases Training program in Bolivia: South-South Training with Peru
-
批准号:10838920
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2024
-
负责人:ROBERT H GILMAN
-
依托单位:
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
-
批准号:10731855
-
项目类别:
-
资助金额:$75.1万
-
财政年份:2023
-
负责人:ROBERT H GILMAN
-
依托单位:
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites
-
批准号:10392356
-
项目类别:
-
资助金额:$65.05万
-
财政年份:2020
-
负责人:ROBERT H GILMAN
-
依托单位:
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites
-
批准号:10598532
-
项目类别:
-
资助金额:$65.2万
-
财政年份:2020
-
负责人:ROBERT H GILMAN
-
依托单位:
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America
-
批准号:10405524
-
项目类别:
-
资助金额:$64.52万
-
财政年份:2018
-
负责人:ROBERT H GILMAN
-
依托单位:
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America
-
批准号:10207356
-
项目类别:
-
资助金额:$64.83万
-
财政年份:2018
-
负责人:ROBERT H GILMAN
-
依托单位:
Oxfendazole as a Broad Spectrum Deworming Medicine in Humans: Phase II Efficacy Study in Geohelminths
-
批准号:9143283
-
项目类别:
-
资助金额:$23.32万
-
财政年份:2016
-
负责人:ROBERT H GILMAN
-
依托单位:
Infectious Diseases Training program in Bolivia: South-South Training with Peru
-
批准号:10580728
-
项目类别:
-
资助金额:$29.39万
-
财政年份:2015
-
负责人:ROBERT H GILMAN
-
依托单位:
Infectious Diseases Training program in Bolivia: South-South Training with Peru
-
批准号:10328561
-
项目类别:
-
资助金额:$29.38万
-
财政年份:2015
-
负责人:ROBERT H GILMAN
-
依托单位:
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community
-
批准号:8961698
-
项目类别:
-
资助金额:$73.16万
-
财政年份:2015
-
负责人:ROBERT H GILMAN
-
依托单位:
Infectious Diseases Training program in Bolivia: South-South Training with Peru
-
批准号:9065693
-
项目类别:
-
资助金额:$26.99万
-
财政年份:2015
-
负责人:ROBERT H GILMAN
-
依托单位:
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
-
批准号:10471779
-
项目类别:
-
资助金额:$70.83万
-
财政年份:2014
-
负责人:ROBERT H GILMAN
-
依托单位:
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
-
批准号:10656420
-
项目类别:
-
资助金额:$71.79万
-
财政年份:2014
-
负责人:ROBERT H GILMAN
-
依托单位:
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
-
批准号:8994261
-
项目类别:
-
资助金额:$59.97万
-
财政年份:2014
-
负责人:ROBERT H GILMAN
-
依托单位:
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
-
批准号:10183142
-
项目类别:
-
资助金额:$71.02万
-
财政年份:2014
-
负责人:ROBERT H GILMAN
-
依托单位:
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
-
批准号:9208732
-
项目类别:
-
资助金额:$58.74万
-
财政年份:2014
-
负责人:ROBERT H GILMAN
-
依托单位:
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
-
批准号:8696019
-
项目类别:
-
资助金额:$67.26万
-
财政年份:2014
-
负责人:ROBERT H GILMAN
-
依托单位:
Family Cluster Analysis of Norovirus Variants by Multiple-region Sequence Typing
-
批准号:8283947
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2012
-
负责人:ROBERT H GILMAN
-
依托单位:
Launching a salt substitute to reduce blood pressure at the population level-Peru
-
批准号:8466372
-
项目类别:
-
资助金额:$46.81万
-
财政年份:2012
-
负责人:ROBERT H GILMAN
-
依托单位:
Macrophage polarization and glutathione levels in the TB-helminth co-infection
-
批准号:8510569
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2012
-
负责人:ROBERT H GILMAN
-
依托单位:
海外基金